AGN
Allergan Plc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.
Market Cap: 63.7 Billion
Primary Exchange: New York Stock Exchange
Website: http://www.allergan.com
Shares Outstanding: 330 Million
Float: 329 Million
Dividend: 2.96 (0.02%)
Beta: 0.4857322161108791
Sector: Health Technology
Industry: Pharmaceuticals: Generic
Ethical Flags
Longest drawdown: 1736 trading days
From: 2015-07-28 To: 2020-05-08
Lowest Point:
FDA Approves Amgen And Allergan's KANJINTI(TM) (trastuzumab-anns), A Biosimilar To Herceptin® (trastuzumab)
via: PR Newswire at 2019-06-13 15:13:00:000
THOUSAND OAKS, Calif. , June 13, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved KANJINTI (trastuzumab-anns) for all approved indications of the reference product, Herceptin … read more...
Billionaires Love 50 Stocks And 31 Of Those Pay Dividends
via: SeekingAlpha at 2019-06-13 10:41:44:000
James Brumley says in Kiplinger Investing : "Rich people often get perpetually richer for a reason, so it could be worthwhile to study what billionaires and high-asset hedge funds are plowing their long-term capital into." As any collection of stocks is more clearly understood when subj… read more...
Akero Therapeutics Readies $75 Million IPO
via: SeekingAlpha at 2019-06-13 09:11:26:000
Quick Take Akero Therapeutics ( AKRO ) has filed to raise gross proceeds of $75.0 million from a U.S. IPO, according to an S-1/A registration statement . The firm is developing a treatment for metabolic diseases with high unmet clinical needs, with an initial focus on non-alcoholic steato… read more...
Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q1 2019 Update
via: SeekingAlpha at 2019-06-13 04:50:49:000
This article is part of a series that provides an ongoing analysis of the changes made to Wallace Weitzs 13F portfolio on a quarterly basis. It is based on Weitzs regulatory 13F Form filed on 05/14/2019. Please visit our Tracking Wallace Weitzs Weitz Investment Manag… read more...
Barclays bearish on Teva, sees 14% downside risk in premarket analyst action
via: SeekingAlpha at 2019-06-11 04:46:44:000
Agilent (NYSE: A ) initiated with Overweight rating and $83 (18% upside) price target at Piper Jaffray. More news on: Agilent Technologies, Inc., Danaher Corporation, Teleflex Incorporated, Healthcare stocks news, Stocks on the move, , Read more … read more...
Barclays bearish on Teva, sees 14% downside risk in premarket analyst action
via: SeekingAlpha at 2019-06-11 04:46:44:000
Agilent (NYSE: A ) initiated with Overweight rating and $83 (18% upside) price target at Piper Jaffray. More news on: Agilent Technologies, Inc., Danaher Corporation, Teleflex Incorporated, Healthcare stocks news, Stocks on the move, , Read more … read more...
FDA Ad Com tomorrow on utility of higher-dose opioids
via: SeekingAlpha at 2019-06-10 13:06:51:000
The FDA's Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee will jointly mee t tomorrow and Wednesday, June 11 & 12, to seek public input on the clinical utility and safety concerns associated with higher range opioid an… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|---|---|---|---|---|---|---|---|
| 2019-08-12 | 2019-09-13 | 2019-08-13 | 2019-07-19 | 0.74 | No Change QoQ | |||
| 2019-05-13 | 2019-06-14 | 2019-05-14 | 2019-05-03 | 0.74 | No Change QoQ | |||
| 2019-02-14 | 2019-03-15 | 2019-02-15 | 2019-01-25 | 0.74 | Increase | |||
| 2018-11-12 | 2018-12-14 | 2018-11-13 | 2018-10-26 | 0.72 | No Change QoQ | |||
| 2018-08-16 | 2018-09-17 | 2018-08-17 | 2018-07-30 | 0.72 | No Change QoQ | |||
| 2018-05-17 | 2018-06-15 | 2018-05-18 | 2018-05-03 | 0.72 | No Change QoQ | |||
| 2018-02-27 | 2018-03-28 | 2018-02-28 | 2018-02-09 | 0.72 | Increase | |||
| 2017-11-16 | 2017-12-15 | 2017-11-17 | 2017-10-27 | 0.7 | No Change QoQ | |||
| 2017-08-16 | 2017-09-15 | 2017-08-18 | 2017-08-02 | 0.7 | No Change QoQ | |||
| 2017-05-16 | 2017-06-15 | 2017-05-18 | 2017-05-05 | 0.7 | No Change QoQ | |||
| 2017-02-24 | 2017-03-28 | 2017-02-28 | 2016-11-02 | 0.7 | Initiation | |||
| 2015-02-05 | 2015-03-20 | 2015-02-09 | 2015-02-04 | 0.05 | No Change QoQ | |||
| 2014-11-18 | 2014-12-11 | 2014-11-20 | 2014-10-27 | 0.05 | No Change QoQ | |||
| 2019-11-12 | 2019-12-13 | 2019-11-13 | 2019-10-25 | 0.74 | Cash | |||
| 2020-02-13 | 2020-03-13 | 2020-02-14 | 2020-01-24 | 0.74 | Cash | |||
| 2020-04-15 | 2020-06-15 | 2020-04-16 | 2020-03-18 | 0.74 | Cash |
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|